CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE2445.959.15 (+0.38 %)
PREV CLOSE ( ) 2436.80
OPEN PRICE ( ) 2424.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6529
TODAY'S LOW / HIGH ( )2363.30 2457.70
52 WK LOW / HIGH ( )1221 2486.65
NSE2446.558.1 (+0.33 %)
PREV CLOSE( ) 2438.45
OPEN PRICE ( ) 2438.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2446.55 (12)
VOLUME 98942
TODAY'S LOW / HIGH( ) 2363.90 2458.45
52 WK LOW / HIGH ( )1222.8 2490

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.